BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  PDL BioPharma Announces Fourth Quarter and Year End 2017 Financial Results

  PDL BioPharma, Inc. reported financial results for the fourth quarter and year ended December 31, 2017.

  March 8, 2018

   · 

  7 min read
• Business

  Tocagen Reports Fourth Quarter and Full Year 2017 Financial and Business Results

  Tocagen Inc. reported financial results and business highlights for the fourth quarter and full year ended December 31, 2017.

  March 8, 2018

   · 

  5 min read
• Business

  BioLife Solutions Announces Fourth Quarter and Full Year 2017 Financial Results

  BioLife Solutions, Inc. reported financial results and operational highlights for the three and 12 months ended December 31, 2017.

  March 8, 2018

   · 

  6 min read
• Business

  AcelRx Pharmaceuticals Reports Fourth Quarter 2017 Financial Results

  AcelRx Pharmaceuticals Inc. reported fourth quarter 2017 financial results.

  March 8, 2018

   · 

  4 min read
• Business

  CytoSorbents Achieves Record Revenue and Product Sales Growth in 2017

  CytoSorbents Corporation achieves record total revenue, CytoSorb sales, and product gross margins in 2017.

  March 8, 2018

   · 

  11 min read
• Business

  Cerus Corporation Reports Record Fourth Quarter and Year End 2017 Results

  Cerus Corporation announced financial results for the fourth quarter and year ended December 31, 2017.

  March 8, 2018

   · 

  6 min read
• Business

  Dicerna Reports Fourth Quarter and Year End 2017 Financial and Operating Results and Provides Corporate Update

  Dicerna Pharmaceuticals Inc. reported financial and operating results for the fourth quarter and full-year ended December 31, 2017.

  March 8, 2018

   · 

  11 min read
• FDA

  TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for TX-001HR

  TherapeuticsMD, Inc. announced the acceptance of the NDA for TX-001HR by the U.S. Food and Drug Administration (FDA).

  March 8, 2018

   · 

  2 min read
• Business

  Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

  Navidea Biopharmaceuticals Inc. announced its financial results for the fourth quarter of 2017. Navidea reported total revenues for the quarter of $395,000.

  March 8, 2018

   · 

  6 min read
• Job Trends

  Biotechnology Company Plans Long-Term Growth, R&D in Central Indiana

  B2S Life Sciences announced plans today to expand its operations in Johnson County, creating up to 23 new, high-wage jobs by 2020.

  March 8, 2018

   · 

  4 min read